Life Biosciences Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Life Biosciences Inc. - overview

Established

2017

Location

Boston, MA, US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded in 2017, Life Biosciences Inc. , a. k. a.


Life Biosciences operates as a life sciences company that focuses on discovering and developing novel therapies to improve the lives of people as they age. In January 2022, Life Biosciences Inc. raised USD 82 million in a Series C funding led by Alpha Wave Global. As of May 2024, Jerry McLaughlin is the CEO of the company.


The company leverages its partial epigenetic reprogramming platform to reprogram the epigenome to resemble that of younger animals using Yamanaka factors, demonstrating success in restoring vision and nerve regeneration in preclinical models. Life Biosciences also utilizes a chaperone-mediated autophagy platform that enhances the degradation of unwanted proteins by increasing the expression of proteins like LAMP2A, showing efficacy in models of frontotemporal dementia, Alzheimer’s disease, and retinal degeneration. These approaches enable Life Biosciences to address unmet medical needs in aging-related diseases.


Current Investors

LeFrak, Alpha Wave Global, Gaingels

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Bioinformatics, Pharmaceutical Research & Development

Website

www.lifebiosciences.com

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.